Adare’s scientific teams boast unprecedented experience in the development of oral solid dosage forms
Our formulation experts partner with you to provide innovative solutions to complex dosage form challenges.
- Dedicated GMP Development Laboratory
- Additional Non-GMP Small Scale Laboratory
- Provides additional early-stage non-GMP development capacity
- Produce smaller batches using less active pharmaceutical ingredients (APIs).
- Mirrors Adare’s pilot and production capabilities
- Start projects immediately
- Faster development timelines
- Integrated R&D validated through to commercial manufacturing
- Full-service capabilities for even the most complex product creation
- In-house regulatory affairs team with a proven global track record
- Flexible Business Model customized to fit your program
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Senior Director of Drug Product Development & Site Leader at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s facilities, supporting a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.